Q3 Earnings Forecast for SAGE Issued By Leerink Partnrs
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Stock analysts at Leerink Partnrs issued their Q3 2025 EPS estimates for shares of Sage Therapeutics in a note issued to investors on Tuesday, February 11th. Leerink Partnrs analyst M. Goodman expects that the biopharmaceutical company will earn ($0.15) per share for the quarter. The consensus estimate […]
More Stories
At Least 11 Injured in Stabbing Attack at Michigan Walmart
By T.J. Muscaro A stabbing incident at a Walmart in Traverse City, Michigan, left at least 11 people injured on...
New York Yankees’ Aaron Judge Headed to Injured List With Elbow Injury
By Ross Kelly The New York Yankees dropped their third straight game on Saturday, falling 9–4 to the Philadelphia Phillies....
Trump Secures Key Trade Agreements Ahead of Aug. 1—Here’s What to Know
By Andrew Moran President Donald Trump has announced a growing list of bilateral trade agreements ahead of the Aug. 1...
How to Delete a Threads Account? Step-by-Step Guide
Just like everyone, I was curious the first time Threads appeared. It was still being referred to as the Twitter...
Andraya Carter’s Wife, Career, Net Worth & Bre Austin Rumors
Andraya Carter has become a famous figure in sports. You might have spotted her on ESPN, or you can even...
Odds of US–EU Trade Deal Are 50–50 Ahead of Tariff Deadline: Trump
By Austin Alonzo President Donald Trump said there’s a 50–50 chance that the United States will finalize a trade deal...